#term ID	term description	observed gene count	background gene count	strength	false discovery rate	matching proteins in your network (IDs)	matching proteins in your network (labels)
PMID:35251002	(2022) Coping With Stress: The Mitokine GDF-15 as a Biomarker of COVID-19 Severity.	5	31	2.46	1.10e-05	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942,9606.ENSP00000351905,9606.ENSP00000471894	GDF15,GFRAL,RET,TGFBR2,HAMP
PMID:29543343	(2018) Hepcidin regulation in a mouse model of acute hypoxia.	4	4	3.25	1.10e-05	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:28501597	(2017) Reciprocal regulation between hepcidin and erythropoiesis and its therapeutic application in erythroid disorders.	4	5	3.15	1.10e-05	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:26124688	(2015) Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions.	4	6	3.07	1.10e-05	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:26712750	(2015) Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia.	5	25	2.55	1.10e-05	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000347942,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,RET,FAM132B,HAMP
PMID:26460251	(2015) Erythropoietic drive is the strongest predictor of hepcidin level in adults with sickle cell disease.	4	7	3.01	1.20e-05	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:33677869	(2021) [Expression of iron-regulating erythroid factors in different types of erythropoiesis disorders].	4	8	2.95	1.54e-05	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:31775479	(2019) [Expression and influencing factors of hepcidin in classical paroxysmal nocturnal hemoglobinuria].	4	8	2.95	1.54e-05	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:29122992	(2018) Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes.	4	8	2.95	1.54e-05	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:30745811	(2019) Imbalance of erythropoiesis and iron metabolism in patients with thalassemia.	4	9	2.9	1.55e-05	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:32344650	(2020) The Effect of Vitamin D3 Supplementation on Hepcidin, Iron, and IL-6 Responses after a 100 km Ultra-Marathon.	4	10	2.85	1.98e-05	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:30834265	(2019) Erythropoiesis and Iron Homeostasis in Non-Transfusion-Dependent Thalassemia Patients with Extramedullary Hematopoiesis.	4	11	2.81	2.47e-05	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:33144847	(2020) Evaluating the Relationship of GDF-15 with Clinical Characteristics, Cardinal Features, and Survival in Multiple Myeloma.	4	13	2.74	3.98e-05	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000351905,9606.ENSP00000471894	GDF15,GFRAL,TGFBR2,HAMP
PMID:25663418	(2015) The use of hypotransferrinemic mice in studies of iron biology.	4	14	2.71	4.74e-05	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:32899941	(2020) Uremic Toxins Affect Erythropoiesis during the Course of Chronic Kidney Disease: A Review.	4	15	2.68	5.61e-05	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:34445593	(2021) GDF15 and Cardiac Cells: Current Concepts and New Insights.	5	67	2.12	6.70e-05	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942,9606.ENSP00000351905,9606.ENSP00000471894	GDF15,GFRAL,RET,TGFBR2,HAMP
PMID:30956958	(2019) Molecular perspective of iron uptake, related diseases, and treatments.	4	17	2.62	7.64e-05	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:32219031	(2020) Iron homeostasis in a mouse model of thalassemia intermedia is altered between adolescence and adulthood.	4	18	2.6	8.81e-05	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:32508832	(2020) GrowthDifferentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint.	5	74	2.08	9.07e-05	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942,9606.ENSP00000351905,9606.ENSP00000471894	GDF15,GFRAL,RET,TGFBR2,HAMP
PMID:31919087	(2021) A role for hepcidin in the anemia caused by Trypanosoma brucei infection.	4	19	2.57	9.60e-05	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000347942,9606.ENSP00000442304	GDF15,TWSG1,RET,FAM132B
PMID:31723763	(2018) Erythroferrone: An Erythroid Regulator of Hepcidin and Iron Metabolism.	4	19	2.57	9.60e-05	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:30369196	(2018) [Iron homeostasis and iron-related disorders].	4	20	2.55	0.00010	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:25580431	(2014) Iron as the key modulator of hepcidin expression in erythroid antibody-mediated hypoplasia.	4	20	2.55	0.00010	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000347942,9606.ENSP00000471894	GDF15,TWSG1,RET,HAMP
PMID:33987030	(2021) The hypoferremic response to acute inflammation is maintained in thalassemia mice even under parenteral iron loading.	4	21	2.53	0.00011	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:35211089	(2021) Iron Homeostasis and Hepcidin Concentration in Patients With Acromegaly.	4	21	2.53	0.00011	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:30958854	(2019) Effect of stimulated erythropoiesis on liver SMAD signaling pathway in iron-overloaded and iron-deficient mice.	4	22	2.51	0.00011	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:31292266	(2019) A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome.	4	21	2.53	0.00011	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:31432710	(2019) GDF15 is an epithelial-derived biomarker of idiopathic pulmonary fibrosis.	4	21	2.53	0.00011	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942,9606.ENSP00000351905	GDF15,GFRAL,RET,TGFBR2
PMID:25710710	(2015) New insights into iron regulation and erythropoiesis.	4	21	2.53	0.00011	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:33344478	(2020) Role of Growth Differentiation Factor 15 in Lung Disease and Senescence: Potential Role Across the Lifespan.	4	23	2.49	0.00013	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942,9606.ENSP00000351905	GDF15,GFRAL,RET,TGFBR2
PMID:31418854	(2020) GDF11 contributes to hepatic hepcidin (HAMP) inhibition through SMURF1-mediated BMP-SMAD signalling suppression.	4	24	2.47	0.00014	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:32318324	(2020) Depriving Iron Supply to the Virus Represents a Promising Adjuvant Therapeutic Against Viral Survival.	4	25	2.45	0.00016	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:29097483	(2017) The relationship between systemic iron homeostasis and erythropoiesis.	4	25	2.45	0.00016	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:24880340	(2014) Identification of erythroferrone as an erythroid regulator of iron metabolism.	4	25	2.45	0.00016	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:32647792	(2020) Controversies on the Consequences of Iron Overload and Chelation in MDS.	4	26	2.44	0.00017	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:29068390	(2017) Does Hypoxia Cause Carcinogenic Iron Accumulation in Alcoholic Liver Disease (ALD)?	4	26	2.44	0.00017	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:31614529	(2019) Anemia of Inflammation with An Emphasis on Chronic Kidney Disease.	4	27	2.42	0.00018	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:24860505	(2014) Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis.	4	30	2.38	0.00026	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:35351601	(2022) Macrophage inhibitory cytokine-1 in cancer: Beyond the cellular phenotype.	3	3	3.25	0.00027	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:35796717	(2022) The Common H202D Variant in GDF-15 Does Not Affect Its Bioactivity but Can Significantly Interfere with Measurement of Its Circulating Levels.	3	3	3.25	0.00027	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:33209838	(2020) The pattern of iron deficiency with and without anemia among medical college girl students in high altitude southern Saudi Arabia.	3	3	3.25	0.00027	9606.ENSP00000347942,9606.ENSP00000442304,9606.ENSP00000471894	RET,FAM132B,HAMP
PMID:28846097	(2017) GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates.	3	3	3.25	0.00027	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:28846099	(2017) GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand.	3	3	3.25	0.00027	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:30258922	(2017) Targeting both sides of the GDF15-GFRAL-RET receptor complex: A new approach to achieve body weight homeostasis.	3	3	3.25	0.00027	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:29051279	(2018) Expansion of EPOR-negative macrophages besides erythroblasts by elevated EPOR signaling in erythrocytosis mouse models.	4	33	2.33	0.00032	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:32948844	(2021) Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome.	3	4	3.13	0.00041	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:33157126	(2021) Treatment with GDF15, a TGFbeta superfamily protein, induces protective effect on retinal ganglion cells.	3	4	3.13	0.00041	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:33450539	(2021) Is the erythropoietin-erythroferrone-hepcidin axis intact in human neonates?	3	4	3.13	0.00041	9606.ENSP00000347942,9606.ENSP00000442304,9606.ENSP00000471894	RET,FAM132B,HAMP
PMID:34157011	(2021) Erythropoiesis and Iron Parameters in Transfusion-dependent and Nontransfusion-dependent Thalassemias.	3	4	3.13	0.00041	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:32661391	(2020) Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice.	3	4	3.13	0.00041	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:32759562	(2020) [Treatment of iron overload in myelodysplastic syndromes and other bone marrow failure syndromes].	3	4	3.13	0.00041	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:32847145	(2020) A Novel Role of Growth Differentiation Factor (GDF)-15 in Overlap with Sedentary Lifestyle and Cognitive Risk in COPD.	3	4	3.13	0.00041	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:33172749	(2020) Insights Into Mechanisms of GDF15 and Receptor GFRAL: Therapeutic Targets.	3	4	3.13	0.00041	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:31775259	(2019) Therapeutic Advances in Regulating the HepcidinFerroportin Axis.	4	37	2.28	0.00041	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:29788292	(2018) Biological Processes Modulating Longevity across Primates: A Phylogenetic Genome-Phenome Analysis.	4	36	2.3	0.00041	9606.ENSP00000230048,9606.ENSP00000252809,9606.ENSP00000256951,9606.ENSP00000397178	ACOT13,GDF15,EMP1,ZNF300
PMID:26182354	(2015) Hepcidin: regulation of the master iron regulator.	4	37	2.28	0.00041	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:19414861	(2009) Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells.	3	4	3.13	0.00041	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:24726864	(2014) Physiology and pathophysiology of iron in hemoglobin-associated diseases.	4	38	2.27	0.00042	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:34435561	(2021) Chronic exposure to MC-LR increases the risks of microcytic anemia: Evidence from human and mice.	3	5	3.03	0.00051	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:28642302	(2017) Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin.	3	5	3.03	0.00051	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:26733771	(2015) HepcidinFerritin Quotient Helps to Predict Spontaneous Recovery from Iron Loss following Blood Donation.	3	5	3.03	0.00051	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:24598841	(2014) Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions.	3	5	3.03	0.00051	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:21886780	(2011) Hepcidin levels and their determinants in different types of myelodysplastic syndromes.	3	5	3.03	0.00051	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:34593305	(2021) GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism.	4	42	2.23	0.00055	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942,9606.ENSP00000471894	GDF15,GFRAL,RET,HAMP
PMID:27442953	(2016) Advances in understanding the mechanisms of erythropoiesis in homeostasis and disease.	4	42	2.23	0.00055	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:35052868	(2022) Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for beta-Thalassemia Patients.	4	43	2.22	0.00058	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:34396049	(2021) A Comprehensive Analysis of the Erythropoietin-erythroferrone-hepcidin Pathway in Hereditary Hemolytic Anemias.	3	6	2.95	0.00067	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:32030737	(2020) Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease.	3	6	2.95	0.00067	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:32973246	(2020) Implementation of a red blood cell-optical (RBO) channel for detection of latent iron deficiency anaemia by automated measurement of autofluorescence-emitting red blood cells.	3	6	2.95	0.00067	9606.ENSP00000347942,9606.ENSP00000442304,9606.ENSP00000471894	RET,FAM132B,HAMP
PMID:29054350	(2018) What can we learn from ineffective erythropoiesis in thalassemia?	4	45	2.2	0.00067	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:30345390	(2018) Associations of vomiting and antiemetic use in pregnancy with levels of circulating GDF15 early in the second trimester: A nested case-control study.	3	6	2.95	0.00067	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:20712768	(2010) Iron metabolism and ineffective erythropoiesis in beta-thalassemia mouse models.	3	6	2.95	0.00067	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:29674655	(2018) Reduced oxidative capacity in macrophages results in systemic insulin resistance.	4	46	2.19	0.00068	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942,9606.ENSP00000351905	GDF15,GFRAL,RET,TGFBR2
PMID:27057839	(2016) Hepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic Review.	4	48	2.17	0.00079	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:34381196	(2021) GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease.	3	7	2.88	0.00085	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:29599085	(2018) Fetal presentation of congenital dyserythropoietic anemia type 1 with novel compound heterozygous CDAN1 mutations.	3	7	2.88	0.00085	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:27905193	(2017) High pretransplant hepcidin levels are associated with poor overall survival and delayed platelet engraftment after allogeneic hematopoietic stem cell transplantation.	3	7	2.88	0.00085	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:26773325	(2016) Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects.	3	7	2.88	0.00085	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:24339866	(2013) Low hepcidin levels in severely anemic malawian children with high incidence of infectious diseases and bone marrow iron deficiency.	3	7	2.88	0.00085	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:33567936	(2021) Elevated circulating growth differentiation factor 15 is related to decreased heart rate variability in chronic kidney disease patients.	3	8	2.82	0.0011	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:34247467	(2021) Serum growth differentiation factor-15 analysis as a malnutrition marker in hemodialysis patients	3	8	2.82	0.0011	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:31928886	(2020) GDF15 Induces Anorexia through Nausea and Emesis.	3	8	2.82	0.0011	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:33396237	(2020) Association between Growth Differentiation Factor-15 (GDF-15) Serum Levels, Anorexia and Low Muscle Mass among Cancer Patients.	3	8	2.82	0.0011	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:33679722	(2020) The Clinical Significance of Iron Overload and Iron Metabolism in Myelodysplastic Syndrome and Acute Myeloid Leukemia.	4	54	2.12	0.0011	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,TWSG1,FAM132B,HAMP
PMID:29093386	(2018) The Impact of Human Parvovirus B19 Infection on Heart Failure and Anemia with Reference to Iron Metabolism Markers in an Adult Woman.	3	8	2.82	0.0011	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:27917462	(2017) Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.	3	8	2.82	0.0011	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:25209728	(2014) Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients.	3	8	2.82	0.0011	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:35292508	(2022) Specific changes of erythroid regulators and hepcidin in patients infected by SARS-COV-2.	3	9	2.77	0.0013	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:33762836	(2021) Increased Serum GDF15 Related to Improvement in Metabolism by Lifestyle Intervention Among Young Overweight and Obese Adults.	3	9	2.77	0.0013	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000351905	GDF15,GFRAL,TGFBR2
PMID:34149933	(2021) Expression of the Body-Weight Signaling Players: GDF15, GFRAL and RET and their clinical relevance in Gastric Cancer.	3	9	2.77	0.0013	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:34638326	(2021) Clinical and Tumor Characteristics of Patients with High Serum Levels of Growth Differentiation Factor 15 in Advanced Pancreatic Cancer.	3	9	2.77	0.0013	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:29316681	(2018) Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management.	3	9	2.77	0.0013	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:30533221	(2018) Weight Loss Induced by Bariatric Surgery Restricts Hepatic GDF15 Expression.	3	9	2.77	0.0013	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000471894	GDF15,GFRAL,HAMP
PMID:22586470	(2012) Hepcidin expression in iron overload diseases is variably modulated by circulating factors.	3	9	2.77	0.0013	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:33903632	(2021) Fc-GDF15 glyco-engineering and receptor binding affinity optimization for body weight regulation.	3	10	2.73	0.0016	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:34189431	(2021) Growth differentiation factor 15 neutralization does not impact anorexia or survival in lipopolysaccharide-induced inflammation.	3	10	2.73	0.0016	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:34538261	(2021) Megaloblastic anemia-related iron overload and erythroid regulators: a case report.	3	10	2.73	0.0016	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:32764826	(2020) Association between GDF15, poverty and mortality in urban middle-aged African American and white adults.	3	10	2.73	0.0016	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:32038278	(2019) Increased Hepcidin Levels During a Period of High Training Load Do Not Alter Iron Status in Male Elite Junior Rowers.	3	10	2.73	0.0016	9606.ENSP00000347942,9606.ENSP00000442304,9606.ENSP00000471894	RET,FAM132B,HAMP
PMID:28135344	(2017) Characterization of Putative Erythroid Regulators of Hepcidin in Mouse Models of Anemia.	3	10	2.73	0.0016	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304	GDF15,TWSG1,FAM132B
PMID:20490352	(2010) Iron overload in sickle cell disease.	3	10	2.73	0.0016	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:20712769	(2010) Hepcidin in beta-thalassemia.	3	10	2.73	0.0016	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:32310257	(2020) GDF15: A Hormone Conveying Somatic Distress to the Brain.	4	65	2.04	0.0018	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942,9606.ENSP00000471894	GDF15,GFRAL,RET,HAMP
PMID:33668309	(2021) Effects of Exercise Intervention on Mitochondrial Stress Biomarkers in Metabolic Syndrome Patients: A Randomized Controlled Trial.	3	11	2.69	0.0019	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:33684239	(2021) Marginally reduced maternal hepatic and splenic ferroportin under severe nutritional iron deficiency in pregnancy maintains systemic iron supply.	3	12	2.65	0.0023	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:34930049	(2021) Is 6-Shogaol an Effective Phytochemical for Patients With Lower-risk Myelodysplastic Syndrome? A Narrative Review.	3	12	2.65	0.0023	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:29342861	(2018) Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease.	3	12	2.65	0.0023	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:34150865	(2021) Growth Differentiation Factor 15 Predicts Cancer Death in Patients With Cardiovascular Risk Factors: The J-HOP Study.	3	13	2.61	0.0028	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:33201838	(2020) Upregulated GDF-15 expression facilitates pancreatic ductal adenocarcinoma progression through orphan receptor GFRAL.	3	13	2.61	0.0028	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000351905	GDF15,GFRAL,TGFBR2
PMID:29981834	(2019) Erythropoietic regulators of iron metabolism.	3	13	2.61	0.0028	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:31392261	(2019) Cryo-EM structure of the activated RET signaling complex reveals the importance of its cysteine-rich domain.	3	14	2.58	0.0033	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:29967567	(2018) CRP Stimulates GDF15 Expression in Endothelial Cells through p53.	3	14	2.58	0.0033	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:25782630	(2015) Evidence that the expression of transferrin receptor 1 on erythroid marrow cells mediates hepcidin suppression in the liver.	3	14	2.58	0.0033	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:25044010	(2014) Hereditary xerocytosis revisited.	3	14	2.58	0.0033	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:22627267	(2013) Hepcidin and iron regulation in health and disease.	3	14	2.58	0.0033	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:22294463	(2012) Known and potential roles of transferrin in iron biology.	3	14	2.58	0.0033	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:20066043	(2010) Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias.	3	14	2.58	0.0033	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:20467559	(2010) Iron Loading and Overloading due to Ineffective Erythropoiesis.	3	14	2.58	0.0033	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:33220493	(2021) Growth differentiation factor 15 as a potential therapeutic for treating obesity.	3	15	2.55	0.0036	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:33442410	(2021) GDF15GFRAL Pathway as a Metabolic Signature for Cachexia in Patients with Cancer.	3	15	2.55	0.0036	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:34187898	(2021) Activation of the hypothalamic-pituitary-adrenal axis by exogenous and endogenous GDF15.	3	15	2.55	0.0036	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:31389184	(2019) Senescence-associated tissue microenvironment promotes colon cancer formation through the secretory factor GDF15.	3	15	2.55	0.0036	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:29889908	(2018) Binding of EphrinA5 to RET receptor tyrosine kinase: An in vitro study.	3	15	2.55	0.0036	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:30542297	(2018) GDF15 and Growth Control.	3	15	2.55	0.0036	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:33716718	(2021) Failure of Glial Cell-Line Derived Neurotrophic Factor (GDNF) in Clinical Trials Orchestrated By Reduced NR4A2 (NURR1) Transcription Factor in Parkinsons Disease. A Systematic Review.	3	16	2.52	0.0041	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:33411243	(2021) Hippocampal and Prefrontal Cortical Brain Tissue Levels of Irisin and GDF15 Receptor Subunits in Children.	3	17	2.5	0.0048	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:33846641	(2021) Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation.	3	17	2.5	0.0048	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:30798811	(2019) Hepcidin-ferroportin axis in health and disease.	3	17	2.5	0.0048	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:31535977	(2019) Cryo-EM analyses reveal the common mechanism and diversification in the activation of RET by different ligands.	3	17	2.5	0.0048	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:26919168	(2016) New strategies to target iron metabolism for the treatment of beta thalassemia.	3	17	2.5	0.0048	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:32629238	(2020) Development of insulin resistance preceded major changes in iron homeostasis in mice fed a high-fat diet.	3	18	2.47	0.0054	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304	GDF15,TWSG1,FAM132B
PMID:32958690	(2020) Hepcidin Is Essential for Alveolar Macrophage Function and Is Disrupted by Smoke in a Murine Chronic Obstructive Pulmonary Disease Model.	3	18	2.47	0.0054	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304	GDF15,TWSG1,FAM132B
PMID:30792208	(2019) New thiazolidinones reduce iron overload in mouse models of hereditary hemochromatosis and beta-thalassemia.	3	18	2.47	0.0054	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000442304	GDF15,TWSG1,FAM132B
PMID:29161287	(2017) TGF-beta contamination of purified recombinant GDF15.	3	18	2.47	0.0054	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000351905	GDF15,GFRAL,TGFBR2
PMID:27557596	(2016) Iron deficiency or anemia of inflammation? : Differential diagnosis and mechanisms of anemia of inflammation.	3	18	2.47	0.0054	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:20508726	(2010) beta-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload.	3	18	2.47	0.0054	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:32502202	(2020) Growth differentiation factor-15 slows the growth of murine prostate cancer by stimulating tumor immunity.	3	19	2.45	0.0060	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000351905	GDF15,GFRAL,TGFBR2
PMID:30157422	(2018) Ret and Substrate-Derived TGF-beta Maverick Regulate Space-Filling Dendrite Growth in Drosophila Sensory Neurons.	3	19	2.45	0.0060	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:20631898	(2010) Crosstalk between Iron Metabolism and Erythropoiesis.	3	19	2.45	0.0060	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:31875646	(2020) GDF15 mediates the effects of metformin on body weight and energy balance.	3	20	2.43	0.0067	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:27756061	(2017) Anaemia of Chronic Disease: An In-Depth Review.	3	20	2.43	0.0067	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:23589789	(2013) Role of hepcidin in the pathophysiology and diagnosis of anemia.	3	20	2.43	0.0067	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:20174612	(2009) Future alternative therapies for beta-thalassemia.	3	20	2.43	0.0067	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:33312159	(2020) GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin.	3	21	2.41	0.0074	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:30666215	(2018) GDNF and the RET Receptor in Cancer: New Insights and Therapeutic Potential.	3	21	2.41	0.0074	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:26009691	(2015) Hepcidin - A novel biomarker with changing trends.	3	21	2.41	0.0074	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:23119007	(2012) The somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cells.	3	21	2.41	0.0074	9606.ENSP00000252809,9606.ENSP00000256951,9606.ENSP00000351905	GDF15,EMP1,TGFBR2
PMID:33773090	(2021) Macrophage inhibitory cytokine-1 induced by a high-fat diet promotes prostate cancer progression by stimulating tumor-promoting cytokine production from tumor stromal cells.	3	22	2.38	0.0082	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:34024778	(2021) Neuroprotective Potential of a Small Molecule RET Agonist in Cultured Dopamine Neurons and Hemiparkinsonian Rats.	3	22	2.38	0.0082	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:32911810	(2020) Small Molecules and Peptides Targeting Glial Cell Line-Derived Neurotrophic Factor Receptors for the Treatment of Neurodegeneration.	3	22	2.38	0.0082	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:24389303	(2014) Hypoxia-inducible factors link iron homeostasis and erythropoiesis.	3	22	2.38	0.0082	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:22306005	(2012) Hepcidin and iron homeostasis.	3	22	2.38	0.0082	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:21520181	(2011) The hepcidin circuits act: balancing iron and inflammation.	3	22	2.38	0.0082	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:21912548	(2011) Hepcidin: A Critical Regulator of Iron Metabolism during Hypoxia.	3	22	2.38	0.0082	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:33484636	(2021) A two-site flexible clamp mechanism for RET-GDNF-GFRalpha1 assembly reveals both conformational adaptation and strict geometric spacing.	3	23	2.37	0.0089	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:32557398	(2020) Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation.	3	23	2.37	0.0089	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:32613776	(2020) The Role of Growth Differentiation Factor 15 in Energy Metabolism.	3	23	2.37	0.0089	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:30836435	(2019) The pathogenesis, diagnosis and management of congenital dyserythropoietic anaemia type I.	3	23	2.37	0.0089	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:31172340	(2019) Fractalkine Induces Hepcidin Expression of BV-2 Microglia and Causes Iron Accumulation in SH-SY5Y Cells.	3	23	2.37	0.0089	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:30469435	(2018) Hepcidin Therapeutics.	3	23	2.37	0.0089	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:22160085	(2011) Unraveling mechanisms regulating systemic iron homeostasis.	3	23	2.37	0.0089	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:33025407	(2021) Biomarkers of iron metabolism in chronic kidney disease.	3	24	2.35	0.0096	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:33842503	(2021) Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents.	3	24	2.35	0.0096	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:34786173	(2021) Direct modulation of hepatocyte hepcidin signaling by iron.	3	24	2.35	0.0096	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:31928885	(2020) Comprehensive Proteomics Analysis of Stressed Human Islets Identifies GDF15 as a Target for Type 1 Diabetes Intervention.	3	24	2.35	0.0096	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:28328181	(2017) Role of hepcidin-ferroportin axis in the pathophysiology, diagnosis, and treatment of anemia of chronic inflammation.	3	24	2.35	0.0096	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:28899900	(2017) Ret receptor tyrosine kinase sustains proliferation and tissue maturation in intestinal epithelia.	3	24	2.35	0.0096	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:24731443	(2014) Hepcidin and sports anemia.	3	24	2.35	0.0096	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:29458727	(2018) Ineffective Erythropoiesis: Anemia and Iron Overload.	3	25	2.33	0.0103	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:29620054	(2018) Haemochromatosis.	3	25	2.33	0.0103	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:29717162	(2018) Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.	3	25	2.33	0.0103	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000351905	GDF15,GFRAL,TGFBR2
PMID:25696858	(2014) Iron age: novel targets for iron overload.	3	25	2.33	0.0103	9606.ENSP00000351905,9606.ENSP00000442304,9606.ENSP00000471894	TGFBR2,FAM132B,HAMP
PMID:21075282	(2010) Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in beta-thalassemia.	3	25	2.33	0.0103	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:35058441	(2022) GDF15 promotes prostate cancer bone metastasis and colonization through osteoblastic CCL2 and RANKL activation.	3	26	2.31	0.0111	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:35283407	(2022) RET receptor signaling: Function in development, metabolic disease, and cancer.	3	26	2.31	0.0111	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:34068996	(2021) EnvIRONmental Aspects in Myelodysplastic Syndrome.	3	26	2.31	0.0111	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:34281283	(2021) Ineffective Erythropoiesis in beta-Thalassaemia: Key Steps and Therapeutic Options by Drugs.	3	26	2.31	0.0111	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:26981017	(2016) Laboratory use of hepcidin in renal transplant recipients.	3	27	2.3	0.0121	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:21864651	(2012) Hereditary hemochromatosis and transferrin receptor 2.	3	27	2.3	0.0121	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:32759740	(2020) RAP-011 Rescues the Disease Phenotype in a Cellular Model of Congenital Dyserythropoietic Anemia Type II by Inhibiting the SMAD2-3 Pathway.	3	28	2.28	0.0132	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:30042411	(2018) Dysregulated iron metabolism in polycythemia vera: etiology and consequences.	3	28	2.28	0.0132	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:26160612	(2015) Iron homeostasis in host defence and inflammation.	3	28	2.28	0.0132	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:23092063	(2012) Iron metabolism: current facts and future directions.	3	28	2.28	0.0132	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:20862391	(2010) Erythropoiesis and iron sulfur cluster biogenesis.	3	28	2.28	0.0132	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:34740612	(2021) Bone morphogenetic protein 6-mediated crosstalk between endothelial cells and hepatocytes recapitulates the iron-sensing pathway in vitro.	3	29	2.26	0.0142	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:32155728	(2020) Stress Erythropoiesis is a Key Inflammatory Response.	3	29	2.26	0.0142	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:21415988	(2009) Iron metabolism in thalassemia and sickle cell disease.	3	29	2.26	0.0142	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:33672223	(2021) The Interplay between Drivers of Erythropoiesis and Iron Homeostasis in Rare Hereditary Anemias: Tipping the Balance.	3	30	2.25	0.0153	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:34594407	(2021) Emerging roles of growth differentiation factor-15 in brain disorders (Review).	3	30	2.25	0.0153	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000351905	GDF15,GFRAL,TGFBR2
PMID:33071961	(2020) GFRalpha 1-2-3-4 co-receptors for RET Are co-expressed in Pituitary Stem Cells but Individually Retained in Some Adenopituitary Cells.	3	30	2.25	0.0153	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:34445261	(2021) The PPARbetadelta-AMPK Connection in the Treatment of Insulin Resistance.	3	31	2.24	0.0165	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:33131246	(2020) Leukemia cells remodel marrow adipocytes via TRPV4-dependent lipolysis.	3	31	2.24	0.0165	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000351905	GDF15,GFRAL,TGFBR2
PMID:30047421	(2018) Critical Issues in Diamond-Blackfan Anemia and Prospects for Novel Treatment.	3	31	2.24	0.0165	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:29333256	(2017) Pathophysiology and treatment of patients with beta-thalassemia - an update.	3	31	2.24	0.0165	9606.ENSP00000262120,9606.ENSP00000442304,9606.ENSP00000471894	TWSG1,FAM132B,HAMP
PMID:26669208	(2016) Modulation of hepcidin to treat iron deregulation: potential clinical applications.	3	31	2.24	0.0165	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:24808863	(2014) Hepcidin antagonists for potential treatments of disorders with hepcidin excess.	3	31	2.24	0.0165	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:34168722	(2021) Role of novel biomarkers in diabetic cardiomyopathy.	3	32	2.22	0.0175	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:30287621	(2019) Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes.	3	32	2.22	0.0175	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:30425709	(2018) GDF15 Regulates Malat-1 Circular RNA and Inactivates NFkappaB Signaling Leading to Immune Tolerogenic DCs for Preventing Alloimmune Rejection in Heart Transplantation.	3	32	2.22	0.0175	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000351905	GDF15,GFRAL,TGFBR2
PMID:32757036	(2020) Mitochondria, immunosenescence and inflammaging: a role for mitokines?	3	33	2.21	0.0188	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:20827391	(2010) Ferroportin and erythroid cells: an update.	3	33	2.21	0.0188	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:25742458	(2015) Anemia: progress in molecular mechanisms and therapies.	3	34	2.2	0.0203	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:20189278	(2010) Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD.	3	34	2.2	0.0203	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:32993133	(2020) RET Receptor Tyrosine Kinase: Role in Neurodegeneration, Obesity, and Cancer.	3	35	2.18	0.0218	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:34439145	(2021) Neural Mechanisms of Cancer Cachexia.	3	36	2.17	0.0235	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:23606813	(2013) Ineffective erythropoiesis in beta -thalassemia.	3	36	2.17	0.0235	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:33015416	(2020) Cardiac Endocrinology: Heart-Derived Hormones in Physiology and Disease.	3	37	2.16	0.0252	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:20420524	(2010) Iron homeostasis and the inflammatory response.	3	37	2.16	0.0252	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:32114309	(2020) Receptor tyrosine kinase activation: From the ligand perspective.	3	38	2.15	0.0269	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:30360575	(2018) The Functional Versatility of Transferrin Receptor 2 and Its Therapeutic Value.	3	38	2.15	0.0269	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:28662101	(2017) Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTENPI3KAKT pathway in lung cancer.	3	38	2.15	0.0269	9606.ENSP00000252809,9606.ENSP00000256951,9606.ENSP00000351905	GDF15,EMP1,TGFBR2
PMID:22306267	(2012) Murine mutants in the study of systemic iron metabolism and its disorders: an update on recent advances.	3	38	2.15	0.0269	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:34220453	(2021) Glial Cell Line-Derived Neurotrophic Factor Family Ligands, Players at the Interface of Neuroinflammation and Neuroprotection: Focus Onto the Glia.	3	39	2.14	0.0284	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:34942967	(2021) Iron Overload, Oxidative Stress, and Ferroptosis in the Failing Heart and Liver.	3	40	2.13	0.0304	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:34562018	(2022) Iron parameters in pregnant women with beta-thalassaemia minor combined with iron deficiency anaemia compared to pregnant women with iron deficiency anaemia alone demonstrate the safety of iron supplementation in beta-thalassaemia minor during ...	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:34614145	(2022) Erythroid overproduction of erythroferrone causes iron overload and developmental abnormalities in mice.	2	2	3.25	0.0323	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:34792309	(2022) Fresh Frozen Plasma Plus Iron Therapy in Congenital Hypotransferrinemia in the Second Decade: A Dynamic Approach to Maintaining Hematological Stability	2	2	3.25	0.0323	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:34935522	(2022) LPS induces rapid increase in GDF15 levels in mice, rats, and humans but is not required for anorexia in mice.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:34974896	(2022) Maternal, fetal and placental regulation of placental iron trafficking.	2	2	3.25	0.0323	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:35464433	(2022) Characterization of Erythroferrone in a Teleost Fish (Dicentrarchus labrax) With Two Functional Hepcidin Types: More Than an Erythroid Regulator.	2	2	3.25	0.0323	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:35482790	(2022) Hepcidin and Erythroferrone Complement the Athlete Biological Passport in the Detection of Autologous Blood Transfusion.	2	2	3.25	0.0323	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:35626166	(2022) GDF15 Is an Eribulin Response Biomarker also Required for Survival of DTP Breast Cancer Cells.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:36001956	(2022) The GDF15-GFRAL pathway is dispensable for the effects of metformin on energy balance.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:36071577	(2022) Erythroferrone contributes to iron mobilization for embryo erythropoiesis in iron-deficient mouse pregnancies.	2	2	3.25	0.0323	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:32619106	(2021) Classic and emergent indicators for the assessment of human iron status.	2	2	3.25	0.0323	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:32866306	(2021) Disordered serum erythroferrone and hepcidin levels as indicators of the spontaneous abortion occurrence during early pregnancy in humans.	2	2	3.25	0.0323	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:33554822	(2021) [Hepcidin and Erythroferrone Levels in Child-Bearing Women with Iron Deficiency Anemia].	2	2	3.25	0.0323	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:33593916	(2021) GFRAL-expressing neurons suppress food intake via aversive pathways.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:33681189	(2021) Gene Expression Profiles Reveal Extracellular Matrix and Inflammatory Signaling in Radiation-Induced Premature Differentiation of Human Fibroblast in vitro.	3	43	2.09	0.0323	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:34218583	(2021) [Effect of iron deficiency level on oral iron absorption].	2	2	3.25	0.0323	9606.ENSP00000347942,9606.ENSP00000471894	RET,HAMP
PMID:34389106	(2021) Iron and erythropoiesis: A mutual alliance.	2	2	3.25	0.0323	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:31655016	(2020) Erythroferrone as a sensitive biomarker to detect stimulation of erythropoiesis.	2	2	3.25	0.0323	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:31991159	(2020) Growth differentiation factor 15 (GDF-15) is a novel orexigen in fish.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:32089755	(2020) Growth Differentiation Factor 15 in Children with Chronic Kidney Disease and after Renal Transplantation.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:32610864	(2020) A Prospective, Randomized, Interventional Study of Oral Iron Supplementation Comparing Daily Dose with Alternate Day Regimen Using Hepcidin as a Biomarker in Iron Deficiency Anemia.	2	2	3.25	0.0323	9606.ENSP00000347942,9606.ENSP00000471894	RET,HAMP
PMID:32702750	(2020) Congenital dyserythropoietic anemias.	2	2	3.25	0.0323	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:32718192	(2020) Evaluation of Erythroferrone, Hepcidin, and Iron Overload Status in Iraqi Transfusion-Dependent beta-Thalassemia Major Patients.	2	2	3.25	0.0323	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:32877689	(2020) An Antibody Attack against Body Wasting in Cancer.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:32936319	(2020) GDF15, an update of the physiological and pathological roles it plays: a review.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:30790643	(2019) Growth differentiation factor 15 (GDF15): A survival protein with therapeutic potential in metabolic diseases.	3	43	2.09	0.0323	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:30882751	(2019) Single versus Split Dose of Iron Optimizes Hemoglobin Mass Gains at 2106 m Altitude.	2	2	3.25	0.0323	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:29282766	(2018) Erythroferrone and iron status parameters levels in pediatric patients with iron deficiency anemia.	2	2	3.25	0.0323	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:29398617	(2018) Exercise increases circulating GDF15 in humans.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:29866502	(2018) Uniting GDF15 and GFRAL: Therapeutic Opportunities in Obesity and Beyond.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:29905937	(2018) Iron overload in patients with myelodysplastic syndromes: An updated overview.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:30382947	(2018) Targeting the divergent TGFbeta superfamily cytokine MIC-1GDF15 for therapy of anorexiacachexia syndromes.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:27658439	(2017) Erythroferrone contributes to hepcidin repression in a mouse model of malarial anemia.	2	2	3.25	0.0323	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:28706390	(2017) The role of discriminant functions in screening beta thalassemia trait and iron deficiency anemia among laboratory samples.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:28846098	(2017) The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:29222456	(2017) BMPs as new insulin sensitizers: enhanced glucose uptake in mature 3T3-L1 adipocytes via PPARgamma and GLUT4 upregulation.	3	41	2.11	0.0323	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000351905	GDF15,GFRAL,TGFBR2
PMID:26871253	(2016) Metabolic regulation of hematopoietic stem cell commitment and erythroid differentiation.	2	2	3.25	0.0323	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:27065587	(2016) Can Serum Gdf-15 be Associated with Functional Iron Deficiency in Hemodialysis Patients?	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:27146013	(2016) Regulation of Hepcidin by Erythropoiesis: The Story So Far.	2	2	3.25	0.0323	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:28428807	(2016) Effect of breastfeeding versus infant formula on iron status of infants with beta thalassemia major.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:25945325	(2015) Non-transfusion-dependent thalassemia: a complex mix of genetic entities yet to be fully discovered.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:26494918	(2015) Erythroferrone: the missing link in beta-thalassemia?	2	2	3.25	0.0323	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:24384540	(2014) Regulation of hepcidin through GDF-15 in cancer-related anemia.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:25267320	(2014) Redistribution of iron towards deposits in erythroblastopenic anemia as a consequence of decreased erythroferrone production.	2	2	3.25	0.0323	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:22983584	(2013) The murine growth differentiation factor 15 is not essential for systemic iron homeostasis in phlebotomized mice.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:23828883	(2013) Hepcidin and beta-thalassemia major.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:21475976	(2011) Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:21518525	(2011) [Effect of GDF15 on iron overloading and erythropoiesis].	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:19047680	(2009) Regulation of growth differentiation factor 15 expression by intracellular iron.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:19120353	(2009) Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:19907155	(2009) Iron metabolism and iron chelation in sickle cell disease.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:20008200	(2009) Molecular mechanisms of normal iron homeostasis.	3	43	2.09	0.0323	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:18272072	(2008) [Erythroblasts-derived GDF15 supresses hepcidin in thalassemia].	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:18824595	(2008) Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I.	2	2	3.25	0.0323	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:34440444	(2021) Complex Interactions in Regulation of Haematopoiesis-An Unexplored Iron Mine.	3	46	2.06	0.0360	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:31222070	(2019) Adaptive adipose tissue stromal plasticity in response to cold stress and antibody-based metabolic therapy.	3	46	2.06	0.0360	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:34575839	(2021) Pathomechanisms of Immunological Disturbances in beta-Thalassemia.	3	47	2.06	0.0380	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:24475022	(2014) An integrative CGH, MSI and candidate genes methylation analysis of colorectal tumors.	3	47	2.06	0.0380	9606.ENSP00000262120,9606.ENSP00000347942,9606.ENSP00000351905	TWSG1,RET,TGFBR2
PMID:32040829	(2020) Anaemia, iron homeostasis and pulmonary hypertension: a review.	3	48	2.05	0.0401	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:30182859	(2019) Neuroregeneration in Parkinsons Disease: From Proteins to Small Molecules.	3	48	2.05	0.0401	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:22406924	(2012) Peginesatide and erythropoietin stimulate similar erythropoietin receptor-mediated signal transduction and gene induction events.	3	48	2.05	0.0401	9606.ENSP00000252809,9606.ENSP00000256951,9606.ENSP00000471894	GDF15,EMP1,HAMP
PMID:34376791	(2022) Serum erythroferrone levels during the first month of life in premature infants.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:34420934	(2022) Multidimensional Biomarker Analysis Including Mitochondrial Stress Indicators for Nonalcoholic Fatty Liver Disease.	3	51	2.02	0.0420	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:34836750	(2022) Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:34849709	(2022) GDF15 in Appetite and Exercise: Essential Player or Coincidental Bystander?	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:34959119	(2022) GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:35177851	(2022) Body weight regulation via MT1-MMP-mediated cleavage of GFRAL.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:35194014	(2022) Growth differentiation factor 15 (GDF15) is associated with non-alcoholic fatty liver disease (NAFLD) in youth with overweight or obesity.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:35628152	(2022) Iron Mining for Erythropoiesis.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:35815815	(2022) Developmental changes in iron metabolism and erythropoiesis in mice with human gain-of-function erythropoietin receptor.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:35935705	(2022) Evaluation of perturbed iron-homeostasis in a prospective cohort of patients with COVID-19.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:36229224	(2022) Contemporary blood doping - performance, mechanism, and detection.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:33228454	(2021) The GDF15-GFRAL Pathway in Health and Metabolic Disease: Friend or Foe?	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:33285302	(2021) Hepatokines and metabolism: Deciphering communication from the liver.	3	52	2.01	0.0420	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:33372284	(2021) Erythroferrone structure, function, and physiology: Iron homeostasis and beyond.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:33486765	(2021) High erythroferrone expression in CD71(+) erythroid progenitors predicts superior survival in myelodysplastic syndromes.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000442304	GDF15,FAM132B
PMID:33822774	(2021) The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a beta-thalassemia mouse model.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:33876222	(2021) Iron homeostasis during anemia of inflammation: a prospective study of patients with tuberculosis.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:33982118	(2021) Serum Erythroferrone During Pregnancy Is Related to Erythropoietin but Does Not Predict the Risk of Anemia.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:34160288	(2021) Effects of altitude and recombinant human erythropoietin on iron metabolism: a randomized controlled trial.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:34209294	(2021) Erythrogram Patterns in Dogs with Chronic Kidney Disease.	2	3	3.07	0.0420	9606.ENSP00000347942,9606.ENSP00000471894	RET,HAMP
PMID:34391699	(2021) Precision therapy for RET-altered cancers with RET inhibitors.	3	49	2.04	0.0420	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:34429084	(2021) Systematic review of specialist selection methods with implications for diversity in the medical workforce.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000262120	GDF15,TWSG1
PMID:34889443	(2021) beta-Thalassemia: evolving treatment options beyond transfusion and iron chelation.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:34944728	(2021) Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism.	3	53	2.0	0.0420	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:31834456	(2020) Erythroferrone, the new iron regulator: evaluation of its levels in Egyptian patients with beta thalassemia.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:31894236	(2020) Testosterone Administration During Energy Deficit Suppresses Hepcidin and Increases Iron Availability for Erythropoiesis.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:32304740	(2020) Functional roles of GDF15 in modulating microenvironment to promote carcinogenesis.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:32430864	(2020) Circulating Cardiac Biomarkers in Diabetes Mellitus: A New Dawn for Risk Stratification-A Narrative Review.	3	49	2.04	0.0420	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:32881623	(2020) The importance of lean mass and iron deficiency when comparing hemoglobin mass in male and female athletic groups.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:30239062	(2019) Hepcidin-25erythroferrone ratio predicts improvement of anaemia in haemodialysis patients treated with ferric citrate hydrate.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:30266734	(2019) Transient decrease of serum iron after acute erythropoietin treatment contributes to hepcidin inhibition by ERFE in mice.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:30755731	(2019) Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:30991401	(2019) Iron Metabolism in Chronic Kidney Disease Patients.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:31000883	(2019) Analysis of GDF15 and IGFBP7 in Hyperemesis Gravidarum Support Causality.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:31071550	(2019) The Growth Differentiation Factor-15 (GDF-15) levels are increased in patients with compound heterozygous sickle cell and beta-thalassemia (HbSbeta(thal)), correlate with markers of hemolysis, iron burden, coagulation, endothelial dysfunction ...	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:31400017	(2019) The BMP-SMAD pathway mediates the impaired hepatic iron metabolism associated with the ERFE-A260S variant.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:31483333	(2019) Can molecular markers of oxygen homeostasis and the measurement of tissue oxygen be leveraged to optimize red blood cell transfusions?	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:31723837	(2019) Cardiac and hepatic siderosis in myelodysplastic syndrome, thalassemia and diverse causes of transfusion-dependent anemia: the TIMES study.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:31808893	(2019) New diagnostic tools for delineating iron status.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:28666715	(2018) [The role of erythroferrone in iron metabolism: From experimental results to pathogenesis].	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:29696062	(2018) Iron deficiency in a tertiary gastroenterology center in Romania: prevalence and significancy.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:30076048	(2018) Inflammation, Hemolysis, and Erythropoiesis Lead to Competitive Regulation of Hepcidin and Possibly Systemic Iron Status in Sickle Cell Disease.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:30224067	(2018) Effect of growth differentiation factor-15 secreted by human umbilical cord blood-derived mesenchymal stem cells on amyloid beta levels in in vitro and in vivo models of Alzheimers disease.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000351905	GDF15,TGFBR2
PMID:30258246	(2018) Evidence GDF15 Plays a Role in Familial and Recurrent Hyperemesis Gravidarum.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:27440164	(2017) Soluble hemojuvelin in transfused and untransfused thalassaemic subjects.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:27684730	(2017) Labile plasma iron, more practical and more sensitive to iron overload in myelodysplastic syndromes.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:27758046	(2017) Hepcidin as a potential biomarker for blood doping.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:27883199	(2017) Hepcidin detects iron deficiency in Sri Lankan adolescents with a high burden of hemoglobinopathy: A diagnostic test accuracy study.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:28033686	(2017) EPO and hepcidin plasma concentrations in blood donors and beta-thalassemia intermedia are not related to commercially tested plasma ERFE concentrations.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:28284299	(2017) Anemia and Red Blood Cell Transfusion: Advances in Critical Care.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:28385068	(2017) Transforming growth factor 15 increased in severe aplastic anemia patients.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:28629515	(2017) Mutual Cross Talk Between Iron Homeostasis and Erythropoiesis.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:28697999	(2017) The protective role of TET2 in erythroid iron homeostasis against oxidative stress and erythropoiesis.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:28739636	(2017) Immunoassay for human serum erythroferrone.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:28953886	(2017) Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:29129392	(2017) Targeting Obesity and Cachexia: Identification of the GFRAL Receptor-MIC-1GDF15 Pathway.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:26970172	(2016) SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:27067488	(2016) EPO-dependent induction of erythroferrone drives hepcidin suppression and systematic iron absorption under phenylhydrazine-induced hemolytic anemia.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:27276035	(2016) Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:25178559	(2015) Growth differentiation factor GDF-15 does not influence iron metabolism in stable chronic haemodialysis patients.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:25631445	(2015) Comprehensive genomic characterization of head and neck squamous cell carcinomas.	3	52	2.01	0.0420	9606.ENSP00000262120,9606.ENSP00000347942,9606.ENSP00000351905	TWSG1,RET,TGFBR2
PMID:25695521	(2015) Macrophage inhibitory cytokine-1 (MIC-1GDF15) gene deletion promotes cancer growth in TRAMP prostate cancer prone mice.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000351905	GDF15,TGFBR2
PMID:25818815	(2015) Comment on: Evaluation of erythrocyte and reticulocyte parameters as indicative of iron deficiency in patients with anemia of chronic disease.	2	3	3.07	0.0420	9606.ENSP00000347942,9606.ENSP00000471894	RET,HAMP
PMID:26276665	(2015) Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of beta-thalassemia.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:26322167	(2015) Is erythroferrone finally the long sought-after systemic erythroid regulator of iron?	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:24533562	(2014) Iron status in patients with pyruvate kinase deficiency: neonatal hyperferritinaemia associated with a novel frameshift deletion in the PKLR gene (p.Arg518fs), and low hepcidin to ferritin ratios.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:25193872	(2014) Erythroferrone contributes to recovery from anemia of inflammation.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:25380934	(2014) Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:23291219	(2013) Regulation of erythropoiesis by hypoxia-inducible factors.	3	49	2.04	0.0420	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:23300182	(2013) Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:23335088	(2013) GDF15-mediated upregulation of ferroportin plays a key role in the development of hyperferritinemia in children with hemophagocytic lymphohistiocytosis.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:23475638	(2013) Treating iron overload in patients with non-transfusion-dependent thalassemia.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:23656728	(2013) Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with beta-thalassemia major: a longitudinal study.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:23731455	(2013) Serum hepcidin and growth differentiation factor-15 (GDF-15) levels in polycythemia vera and essential thrombocythemia.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:23917168	(2013) Out of balance--systemic iron homeostasis in iron-related disorders.	3	49	2.04	0.0420	9606.ENSP00000252809,9606.ENSP00000262120,9606.ENSP00000471894	GDF15,TWSG1,HAMP
PMID:22457245	(2012) Suppressed hepcidin expression correlates with hypotransferrinemia in copper-deficient rat pups but not dams.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:23114598	(2012) Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:21772749	(2011) To umbrella the gonads in transfusion rain.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:19863534	(2010) Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:20133896	(2010) Increased serum hepcidin and alterations in blood iron parameters associated with asymptomatic P. falciparum and P. vivax malaria.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:20415234	(2010) [Clinical usefulness of reticulocyte hemoglobin equivalent (RET-He) in patients at the pre-dialysis stage and in patients on peritoneal dialysis].	2	3	3.07	0.0420	9606.ENSP00000347942,9606.ENSP00000471894	RET,HAMP
PMID:20001631	(2009) Pathophysiology of transfusional iron overload: contrasting patterns in thalassemia major and sickle cell disease.	2	3	3.07	0.0420	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:27725588	(....) hepcidin.	2	3	3.07	0.0420	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:33672218	(2021) Iron Deficiency in Pulmonary Arterial Hypertension: A Deep Dive into the Mechanisms.	3	56	1.98	0.0475	9606.ENSP00000252809,9606.ENSP00000442304,9606.ENSP00000471894	GDF15,FAM132B,HAMP
PMID:31817636	(2019) 27th Annual GP2A Medicinal Chemistry Conference.	3	56	1.98	0.0475	9606.ENSP00000252809,9606.ENSP00000343636,9606.ENSP00000347942	GDF15,GFRAL,RET
PMID:35751642	(2022) Biomarkers for iron metabolism among patients hospitalized with community-acquired pneumonia caused by infection with SARS-CoV-2, bacteria, and influenza.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:31919080	(2021) Induction of erythroferrone in healthy humans by micro-dose recombinant erythropoietin or high-altitude exposure.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:32965044	(2021) A new diagnostic indication device of a biomarker growth differentiation factor 15 for mitochondrial diseases: From laboratory to automated inspection.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:33151561	(2021) Macrophage inhibitory cytokine-1 promotes angiogenesis by eliciting the GFRAL-mediated endothelial cell signaling.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:33231101	(2021) The Role of Iron in Benign and Malignant Hematopoiesis.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:33481341	(2021) Comparison of the effects of weekly and biweekly intravenous CERA administration on erythropoiesis: A randomized controlled trial.	2	4	2.95	0.0481	9606.ENSP00000347942,9606.ENSP00000471894	RET,HAMP
PMID:34236433	(2021) Umbilical Cord Erythroferrone Is Inversely Associated with Hepcidin, but Does Not Capture the Most Variability in Iron Status of Neonates Born to Teens Carrying Singletons and Women Carrying Multiples.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:34310730	(2021) Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:34535626	(2021) Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:34753505	(2021) Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:34827208	(2021) Physical Training Increases Erythroferrone Levels in Men.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:31737919	(2020) Gain-of-function mutations in PIEZO1 directly impair hepatic iron metabolism via the inhibition of the BMPSMADs pathway.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:31800957	(2020) Erythroferrone lowers hepcidin by sequestering BMP26 heterodimer from binding to the BMP type I receptor ALK3.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:31896114	(2020) Growth Differentiation Factor 15 Promotes Progression of Esophageal Squamous Cell Carcinoma via TGF-beta Type II Receptor Activation.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000351905	GDF15,TGFBR2
PMID:32311143	(2020) Androgens stimulate erythropoiesis through the DNA-binding activity of the androgen receptor in non-hematopoietic cells.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:32451387	(2020) A biomathematical model of human erythropoiesis and iron metabolism.	2	4	2.95	0.0481	9606.ENSP00000347942,9606.ENSP00000471894	RET,HAMP
PMID:33134478	(2020) Association of serum growth differentiation factor-15 with eGFR and hemoglobin in healthy older females.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:33149778	(2020) Endurance of erythrocyte series in chemotherapy.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:33281618	(2020) A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum HepcidinErythroferrone Levels.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:30193381	(2019) Cord Blood Erythropoietin and Hepcidin Reflect Lower Newborn Iron Stores due to Maternal Obesity during Pregnancy.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:30232784	(2019) Deregulated iron metabolism in bone marrow from adenine-induced mouse model of chronic kidney disease.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:30633545	(2019) GDF-15 in Pulmonary and Critical Care Medicine.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:30646851	(2019) Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:31152154	(2019) GDF15 mediates adiposity resistance through actions on GFRAL neurons in the hindbrain APNTS.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:31515515	(2019) Nausea and vomiting of pregnancy and hyperemesis gravidarum.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:31700902	(2019) The effect of red blood cell transfusion on plasma hepcidin and growth differentiation factor 15 in gastric cancer patients: a prospective study.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:30070999	(2018) GDF15 deficiency promotes high fat diet-induced obesity in mice.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:30184485	(2018) The MIC-1GDF15-GFRAL Pathway in Energy Homeostasis: Implications for Obesity, Cachexia, and Other Associated Diseases.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000343636	GDF15,GFRAL
PMID:30295269	(2018) [Oxidative Stress Status and Its Effect on Regulation of Hepcidin in Patients with HbHCS].	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:30325657	(2018) Mechanisms responsible for reduced erythropoiesis during androgen deprivation therapy in men with prostate cancer.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:30351387	(2018) An intensified training schedule in recreational male runners is associated with increases in erythropoiesis and inflammation and a net reduction in plasma hepcidin.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:27974599	(2017) Dietary strategies for improving iron status: balancing safety and efficacy.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:28151426	(2017) Decreasing TfR1 expression reverses anemia and hepcidin suppression in beta-thalassemic mice.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:28185024	(2017) Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:28424258	(2017) Serum Hepcidin Concentrations Decline during Pregnancy and May Identify Iron Deficiency: Analysis of a Longitudinal Pregnancy Cohort in The Gambia.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:29070548	(2017) Excess iron: considerations related to development and early growth.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:29261151	(2017) Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:26592557	(2016) Characterization of iron metabolism and erythropoiesis in erythrocyte membrane defects and thalassemia traits.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:26915437	(2016) Evidence of relative iron deficiency in platelet- and plasma-pheresis donors correlates with donation frequency.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:27161430	(2016) The mutual control of iron and erythropoiesis.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:25616571	(2015) Reversal of hemochromatosis by apotransferrin in non-transfused and transfused Hbbth3+ (heterozygous B1B2 globin gene deletion) mice.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:25998917	(2015) Relationship between hepcidin and GDF15 in anemic patients with type 2 diabetes without overt renal impairment.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:26496240	(2015) Plasma hepcidin in early-stage breast cancer patients: no relationship with interleukin-6, erythropoietin and erythroferrone.	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:25052873	(2014) Hepcidin and GDF15 in anemia of multiple myeloma.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:25551924	(2014) The role of hepcidin and its related genes (BMP6, GDF-15, and HJV) in rats exposed to ischemia and reperfusion.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:23098343	(2013) Transient impairment of reticulocyte hemoglobin content and hepcidin-25 induction in patients with community-acquired pneumonia.	2	4	2.95	0.0481	9606.ENSP00000347942,9606.ENSP00000471894	RET,HAMP
PMID:22365732	(2012) Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancy.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:23046381	(2012) Understanding cytokine and growth factor receptor activation mechanisms.	3	59	1.96	0.0481	9606.ENSP00000256951,9606.ENSP00000347942,9606.ENSP00000351905	EMP1,RET,TGFBR2
PMID:21149632	(2011) Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:21276178	(2011) Hepcidin, anaemia, and prostate cancer.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:21535154	(2011) Erythropoietin, GDF15, IL6, hepcidin and testosterone levels in a large cohort of elderly individuals with anaemia of known and unknown cause.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:21815188	(2011) Erythrocyte pyruvate kinase deficiency in an old-order Amish cohort: longitudinal risk and disease management.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:21933404	(2011) Takayasus arteritis presenting with temporary loss of vision in a 23-year-old woman with beta thalassemia trait: a case report.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:22287873	(2011) Management of transfusional iron overload - differential properties and efficacy of iron chelating agents.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:19833632	(2010) Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:20210929	(2010) Expression of growth differentiation factor 15 is not elevated in individuals with iron deficiency secondary to volunteer blood donation.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:21415986	(2009) Thalassaemia intermedia: an update.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:18641032	(2008) Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:18657084	(2008) Behavioral, biochemical, and genetic analysis of iron metabolism in high-intensity blood donors.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:17721544	(2007) High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.	2	4	2.95	0.0481	9606.ENSP00000252809,9606.ENSP00000471894	GDF15,HAMP
PMID:30305507	(....) [myelodysplastic syndromes and iron metabolism].	2	4	2.95	0.0481	9606.ENSP00000442304,9606.ENSP00000471894	FAM132B,HAMP
PMID:33669537	(2021) Tumor Immune Evasion Induced by Dysregulation of Erythroid Progenitor Cells Development.	3	60	1.95	0.0493	9606.ENSP00000252809,9606.ENSP00000347942,9606.ENSP00000471894	GDF15,RET,HAMP
